Acular and Evista drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acular (ketorolac tromethamine) and Evista (raloxifene hydrochloride). Common drug interactions include hip fracture among females.

The phase IV clinical study analyzes what interactions people have when they take Acular and Evista. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Acular?

Acular has active ingredients of ketorolac tromethamine. eHealthMe is studying from 1,125 Acular users. Check the latest studies of Acular.

What is Evista?

Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.



On Jul, 10, 2026

13 people who take Acular and Evista together, and have interactions are studied.

Acular and Evista drug interactions.

What are the common drug interactions of Acular and Evista, by gender? *:

female:

  1. Hip fracture
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Weight decreased
  4. Accident
  5. Ankle fracture
  6. Arthralgia (joint pain)
  7. Blood glucose decreased
  8. Eructation (release of gas from the digestive tract)
  9. Eye pain
  10. Flatulence (flatus expelled through the anus)

male:

n/a

What are the common drug interactions of Acular and Evista, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Pulmonary embolism (blockage of the main artery of the lung)

60+:

  1. Hip fracture
  2. Cataract (clouding of the lens inside the eye)
  3. Accident
  4. Ankle fracture
  5. Arthralgia (joint pain)
  6. Blood glucose decreased
  7. Eructation (release of gas from the digestive tract)
  8. Eye pain
  9. Flatulence (flatus expelled through the anus)
  10. Hand fracture

What are the existing conditions these people have? *

  1. Wound Infection: 3 people, 23.08%
  2. Depression: 3 people, 23.08%
  3. Sleep Disorder: 3 people, 23.08%
  4. Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 23.08%
  5. Post-Traumatic Stress Disorder: 3 people, 23.08%
  6. Pain: 3 people, 23.08%
  7. Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 23.08%
  8. Constipation: 3 people, 23.08%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 23.08%
  10. Stress And Anxiety: 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take Acular and Evista?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acular and Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acular:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acular and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Evista and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ketorolac tromethamine and raloxifene hydrochloride (the active ingredients of Acular and Evista, respectively), and Acular and Evista (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: